|
Her2 expert out of UCLA (pradtices out of Santa Monica Hospital affiliate, I think) is Mark Pegram who has worked many years with Dennis Slamon, who first described her2neu and was instrumental in the discovery of herceptin. Dr. Slamon no longer sees patients, but refers patients to see Dr. Pegram.
The oncologists have gotten together and come up with a "common policy" since there is no time to come up with a Clinical trial as to what to do with people already started on, in the middle of, or already finished with treatment, so don't expect to hear anythiing much different than the "common dogma"--but perhaps he will be thoughtful. The reason for this "common policy" is that NOONE REALLY KNOWS and it is not practical to start a trial now to find out.
So...Good luck!
Lani
|